New Drug-Eluting Balloon Matches Standard Stents in Safety and Effectiveness: SELUTION4ISR Trial
USA: A newdrug-eluting balloon (DEB)may offer a safer and equally effective alternative to conventional metallicstentsfor patients with coronaryin-stent restenosis (ISR), according to the results of theSELUTION4ISR Trial, an international study led by researchers at Mount Sinai Hospital, New York. The findings, presented at theTranscatheter Cardiovascular Therapeutics (TCT) 2025conference in San Francisco, mark a major advancement in interventional cardiology. Key Findings: TCT 2025: Transcatheter Cardiovascular Therapeutics
Disclaimer: This website is designed for healthcare professionals and serves solely for informational purposes.
The content provided should not be interpreted as medical advice, diagnosis, treatment recommendations, prescriptions, or endorsements of specific medical practices. It is not a replacement for professional medical consultation or the expertise of a licensed healthcare provider.
Given the ever-evolving nature of medical science, we strive to keep our information accurate and up to date. However, we do not guarantee the completeness or accuracy of the content.
If you come across any inconsistencies, please reach out to us at
admin@doctornewsdaily.com.
We do not support or endorse medical opinions, treatments, or recommendations that contradict the advice of qualified healthcare professionals.
By using this website, you agree to our
Terms of Use,
Privacy Policy, and
Advertisement Policy.
For further details, please review our
Full Disclaimer.
0 Comments
Post a comment
No comments yet. Be the first to comment!